The efficacy and safety of BV-ICE salvage therapy for relapsed/refractory Hodgkin lymphoma. A single centre
Curr Res Transl Med
.
2022 Jul;70(3):103339.
doi: 10.1016/j.retram.2022.103339.
Epub 2022 Mar 23.
Authors
Jean El Cheikh
1
,
Ghid Amhaz
2
,
Ammar Zahreddine
3
,
Iman Abou Dalle
2
,
Ali Bazarbachi
2
Affiliations
1
Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: je46@aub.edu.lb.
2
Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
3
Department of Nursing, American University of Beirut Medical Center, Beirut, Lebanon.
PMID:
35339033
DOI:
10.1016/j.retram.2022.103339
No abstract available
Publication types
Letter
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Hodgkin Disease* / drug therapy
Hodgkin Disease* / pathology
Humans
Neoplasm Recurrence, Local / drug therapy
Salvage Therapy